Our Recommendations
- Where Women Have No Doctor - Chapter 31 - Use of Medicines in Women’s Health (2014)
- Indicator-Based Pharmacovigilance Assessment Tool: Manual for Conducting Assessments in Developing Countries. (2009)
- MSF Essential Drugs - Practical Guidelines 2022 (2022)
- MSF Médicaments Essentiels - Guide pratique d'utilisation 2022 (2022)
- Infection Control Assessment Tool (2009)
New Publications
- Enhancing Pharmacovigilance in Sub‑Saharan Africa Through Training and Mentoring: A GSK Pilot Initiative in Malawi (2020)
- Landscape analysis of pregnancy exposure registries in low- and middle-income countries (2024)
- Medication safety for look-alike, sound-alike medicines (2023)
- 5 Momentos Clave para la utilización segura de los medicamentos (2019)
- Knowledge and skills reference guide for professional development in diabetes – A companion to the FIP diabetes handbook for pharmacists (2022)
Filter
70
Featured
Recommendations
8
New Publications
22
Language
Document type
Guidelines
32
Studies & Reports
16
Manuals
8
Videos
3
Strategic & Response Plan
3
Fact sheets
3
Training Material
2
Online Courses
2
Resource Platforms
1
Countries / Regions
Latin America and the Carribbean
6
Kenya
2
Argentina
2
South Africa
2
Somalia
2
Ghana
1
Malawi
1
Global
1
Tanzania
1
Ethiopia
1
India
1
Authors & Publishers
Publication Years
Category
Countries
13
Capacity Building
8
Clinical Guidelines
5
Key Resources
4
Pharmacy & Technologies
3
Public Health
2
Women & Child Health
2
Toolboxes
General Guidelines for Rational Use
24
Pharmacovigilance
22
Pharmaceutical Dosage Forms
5
Various Target Groups
5
Many vaccines and drugs hold the promise of reducing mortality and morbidity among pregnant women and infants living in low- and middle-income countries (LMICs). However, sufficient information on the safety of drugs and vaccines in pregnant women is rarely available at the time of product licensure...
Medication errors are a leading cause of patient harm globally. WHO launched the Global Patient Safety Challenge: Medication Without Harm, with the objective of preventing severe medication related patient harm globally. This publication is one of the documents in the WHO Technical Series on “Medi...
A toolkit for pharmacists.
Emerging data show that medication errors and adverse events cause significant harm to patients’ health and
well-being. It is estimated that the burden of adverse events due to medicines is now comparable to that of
widespread diseases, such as malaria or tuberculosis...
Guide pratique d’utilisation à l'usage des médecins, pharmaciens, infirmiers et auxiliaires de santé.
This course is based on the Manual on Safety in Administering Medicines for Neglected Tropical Diseases which provides practical tools, training modules and jobs aids to further improve the planning, preparation, and monitoring of safe administration of NTD medicines.
This Knowledge and Skills reference guide to support professional desvelopment in diabetes is intendet to help pharmacists with the increasingly necessary competencies they may have to acquire in managing patients with diabetes. There roles range from prevention and acreening to clinical management....
This course introduces participants to the foundations of vaccine pharmacovigilance. The aim of this course is to provide healthcare professionals whose work involve vaccine safety issues, with essential knowledge about vaccines and their safety aspects. These professionals can include nurses, midwi...
Accessed on 15.08.2022
La farmacovigilancia es una herramienta que permite la detección, evaluación, conocimiento y prevención de efectos adversos y/o inesperados de los medicamentos que se prescriben. También facilita la detección de fallas de respuesta terapéutica por deficiencias de calid...
MSF Essential Drugs - Practical Guidelines 2022
recommended
Practical guide intended for physicians, pharmacists, nurses and medical auxiliaries. This guide is not a dictionary of pharmacological agents. It is a practical manual intended for health professionals, physicians, pharmacists, nurses and health auxiliaries invoved in curative care and drug managem...
La vigilancia de la resistencia a los antimicrobianos (RAM) desempeña un papel importante en la detección temprana de cepas resistentes que revisten gran importancia para la salud pública, así como en la respuesta rápida a los brotes en los hospitales y en la comunidad. Los resultados de la vig...
Antimicrobial resistance (AMR) surveillance plays an important role in the early detection of resistant strains of public health importance and prompt response to outbreaks in hospitals and the community. Surveillance findings are needed to inform medical practice, antibiotic stewardship, and policy...
This manual summarizes key issues related to the safety of NTD medicines and their administration, with a focus on essential medicines used in mass drug administration (MDA), also called preventive chemotherapy. It can be used as a standalone reference manual, but is intended to be used in conjuncti...
13 July 2021
The module provides an overview of factors to consider when monitoring the safety of COVID-19 vaccines administered to pregnant and breastfeeding women. It describes how national routine AEFI surveillance should be adapted to cater for this specific group of population using both pass...
The Pharmacovigilance team in WHO aims to assure the safety of medicines and vaccines by ensuring reliable and timely exchange of information on safety issues, promoting pharmacovigilance activities throughout the Organization and encouraging participation in the WHO Programme for International Drug...
The PHC STGs and EML should be used by healthcare workers providing care at clinics, community health centres, and gateway clinics at hospitals.
Pharmaceutical and Therapeutics Committees (PTCs) are responsible for ensuring the availability of medicines listed in the PHC EML at those facilities, as...
Introduction Pharmacovigilance (PV) systems to monitor drug and vaccine safety are often inadequate in sub-Saharan
Africa. In Malawi, a PV enhancement initiative was introduced to address major barriers to PV.
Objective The objective of this initiative was to improve reporting of adverse events (A...
Please find all relevant guidelines and information on antimicrobial resistance AMR in our new AMR TOOLBOX
www.amrbox.org
The purpose of this document is to provide relevant information and guidelines on
coronavirus outbreaks – and in particular the novel coronavirus SARS-CoV-2 and the
diseases it produces, COVID-19 – for pharmacists and the pharmacy workforce, both in a
primary care context (i.e. community phar...
